Ariel Kantor is a scientist and entrepreneur at Versant Ventures. He previously held leadership roles at ReCode Therapeutics and co-founded companies in genetic medicines and RNA biology.
At firms with a similar stage, sector and check size.




One email when Ariel's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAriel Kantor is a scientist and entrepreneur at Versant Ventures. He previously held leadership roles at ReCode Therapeutics and co-founded companies in genetic medicines and RNA biology.
Versant Ventures has not reported a check size. It invests at seed, series a, series b.
A warm intro from a founder Versant Ventures backed works best.
investment banker at Evercore Partners; Entrepreneur-in-Residence at Oxford Science Enterprises; Chief Business Officer at ReCode therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.